Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 5 | 39341267 | missense variant | A/C | snv | 3.2E-04 | 1.3E-04 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases | 0.800 | 1.000 | 1 | 1998 | 1998 | ||||||
|
0.925 | 0.040 | 5 | 39331792 | missense variant | G/A | snv | 5.2E-03 | 6.1E-03 |
|
0.800 | 1.000 | 1 | 2013 | 2013 | |||||||
|
5 | 39421634 | intron variant | G/A | snv | 0.37 |
|
0.700 | 1.000 | 2 | 2019 | 2019 | ||||||||||
|
1.000 | 0.080 | 5 | 39397030 | intron variant | T/A | snv | 0.39 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 2 | 2010 | 2012 | |||||||
|
1.000 | 0.080 | 5 | 39397030 | intron variant | T/A | snv | 0.39 |
|
0.700 | 1.000 | 2 | 2010 | 2016 | ||||||||
|
1.000 | 0.080 | 5 | 39397030 | intron variant | T/A | snv | 0.39 |
|
0.700 | 1.000 | 2 | 2016 | 2019 | ||||||||
|
5 | 39393631 | intron variant | G/A | snv | 0.39 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.040 | 5 | 39324690 | intron variant | G/A | snv | 3.1E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 5 | 39314645 | intron variant | T/C | snv | 8.0E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 5 | 39397030 | intron variant | T/A | snv | 0.39 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||||
|
5 | 39400203 | intron variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
1.000 | 0.040 | 5 | 39332304 | intron variant | C/T | snv | 0.27 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 5 | 39318734 | intron variant | G/A | snv | 3.1E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 5 | 39378013 | intron variant | C/T | snv | 0.33 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.080 | 5 | 39378013 | intron variant | C/T | snv | 0.33 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
5 | 39404425 | intron variant | T/- | del | 0.33 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.040 | 5 | 39308949 | intron variant | T/C | snv | 0.41 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
5 | 39424526 | intron variant | A/C | snv | 0.56 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
5 | 39424526 | intron variant | A/C | snv | 0.56 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
5 | 39424526 | intron variant | A/C | snv | 0.56 |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
1.000 | 0.040 | 5 | 39315643 | intron variant | G/A | snv | 0.29 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 5 | 39394887 | intron variant | C/A | snv | 0.98 |
|
Digestive System Diseases; Neoplasms; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.120 | 5 | 39394887 | intron variant | C/A | snv | 0.98 |
|
Digestive System Diseases; Neoplasms; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.040 | 5 | 39316320 | intron variant | C/T | snv | 0.40 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 5 | 39385539 | intron variant | A/C;G | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 |